IMI 8th Call webinars

Start Date 06/12/2012 End Date 09/01/2013

IMI held webinars on all 8th Call topics as well as its rules and procedures in December 2012 and January 2013.

All topic webinars featured a presentation of the Call topic by the EFPIA topic coordinator as well as time for questions and answers. The webinars therefore represented an excellent opportunity to learn more about the topics, interact directly with the topic coordinators, and get in touch with potential project partners. The webinar on IMI’s rules and procedures included presentations of IMI's rules and procedures, its intellectual property policy, and tips on the preparation of an Expression of Interest.

Presentations on the Call topics

European Induced Pluripotent Stem Cell Bank
Devyn Smith, Pfizer

Developing an aetiology-based taxonomy of human disease
Duncan McHale, UCB

Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C
Seamus O’Brien, AstraZeneca and Hasan Jafri, MedImmune

ND4BB Topic 3: Discovery and development of new drugs combatting Gram-negative infections
Rob Stavenger for EFPIA partners (AstraZeneca, Basilea, GlaxoSmithKline, & Sanofi)

Presentations on IMI’s rules and procedures

IMI’s Call procedures
Nathalie Seigneuret, Senior Scientific Project Manager, IMI

Financial and IPR matters
Magali Poinot, Legal Manager, IMI

Writing a successful proposal
Hugh Laverty, Senior Scientific Project Manager, IMI

Background documents

The final version of the 8th Call text can be found on the 8th Call Stage 1 web page